Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Autoimmune Disorders

  Free Subscription


22.07.2024

1 Ann Neurol
4 Brain
1 Diabetes
7 Diabetes Res Clin Pract
3 J Autoimmun
2 J Clin Endocrinol Metab
1 J Nephrol
2 J Neurol
2 Lancet Neurol
2 Neurology
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. FALSO S, Gessi M, Marini S, Benvenuto R, et al
    Cancer Frequency in MuSK Myasthenia Gravis and Histological Evidence of Paraneoplastic Etiology.
    Ann Neurol. 2024 Jul 15. doi: 10.1002/ana.27033.
    PubMed         Abstract available


    Brain

  2. HOLM RP, Wandall-Holm MF, Magyari M
    Multiple sclerosis in Denmark (1950-2023): mean age, sex distribution, incidence and prevalence.
    Brain. 2024 Jul 20:awae245. doi: 10.1093.
    PubMed         Abstract available

  3. TAYLOR BV, Ponsonby AL, Stein M, Lucas R, et al
    Reply: Putative benefits of vitamin D supplements in multiple sclerosis out of reach due to sample size.
    Brain. 2024 Jul 19:awae246. doi: 10.1093.
    PubMed        

  4. SCHNEIDER-HOHENDORF T, Wunsch C, Falk S, Raposo C, et al
    Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation.
    Brain. 2024 Jul 18:awae244. doi: 10.1093.
    PubMed         Abstract available

  5. CORSTEN CEA, Wokke BHA, Smolders J
    Putative benefits of vitamin D supplements in multiple sclerosis out of reach due to sample size.
    Brain. 2024 Jul 16:awae238. doi: 10.1093.
    PubMed        


    Diabetes

  6. YANG Z, Zhang Z, Li L, Jing Z, et al
    Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9 Ameliorate New-onset Type 1 Diabetes.
    Diabetes. 2024 May 21:db230987. doi: 10.2337/db23-0987.
    PubMed         Abstract available


    Diabetes Res Clin Pract


  7. New Understanding Diabetes course on Continuous Glucose Monitoring (CGM).
    Diabetes Res Clin Pract. 2024;213:111766.
    PubMed        

  8. KUGATHASAN L, Sridhar VS, Lytvyn Y, Lovblom LE, et al
    Effect of hyperglycemia and empagliflozin on markers of cardiorenal injury and inflammation in patients with type 1 diabetes.
    Diabetes Res Clin Pract. 2024;213:111764.
    PubMed         Abstract available

  9. JIA Y, Long D, Yang Y, Wang Q, et al
    Diabetic peripheral neuropathy and glycemic variability assessed by continuous glucose monitoring: A systematic review and meta-analysis.
    Diabetes Res Clin Pract. 2024;213:111757.
    PubMed         Abstract available

  10. RIDE J, Cameron L, Jones R, Hall T, et al
    Participation and psychosocial supports in the school setting for children with type 1 diabetes: A discrete choice experiment of carer priority.
    Diabetes Res Clin Pract. 2024;213:111753.
    PubMed         Abstract available

  11. RIPOLI C, Ricciardi MR, Angelo MR, Meloni G, et al
    Incidence of type 1 diabetes in Sardinian children aged 0-14 years has almost doubled in the last twenty years. On top of the world.
    Diabetes Res Clin Pract. 2024;213:111750.
    PubMed         Abstract available

  12. RUSSO G, De Cosmo S, Di Bartolo P, Lucisano G, et al
    The quality of care in type 1 and type 2 diabetes - A 2023 update of the AMD Annals initiative.
    Diabetes Res Clin Pract. 2024;213:111743.
    PubMed         Abstract available

  13. LIU Y, Rao J, Hu W, Yu Y, et al
    Genetic Causality between Type 1 Diabetes and Arrhythmia Identified by a Two-sample Mendelian Randomization Study.
    Diabetes Res Clin Pract. 2024;213:111725.
    PubMed         Abstract available


    J Autoimmun

  14. LEI L, Feng S
    Immune interplay from circulation to local lesion in pemphigus pathogenesis.
    J Autoimmun. 2024;147:103261.
    PubMed         Abstract available

  15. SOLIGNAC M, Cabrera N, Fouillet-Desjonqueres M, Duquesne A, et al
    JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study.
    J Autoimmun. 2024;147:103248.
    PubMed         Abstract available

  16. MANNING JE, Harris E, Mathieson H, Sorensen L, et al
    Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigue.
    J Autoimmun. 2024;147:103260.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  17. LUPO MA, Olivo PD, Luffy M, Wolf J, et al
    US-based, Prospective, Blinded Study of Thyrotropin Receptor Antibody in Autoimmune Thyroid Disease.
    J Clin Endocrinol Metab. 2024 Jul 19:dgae448. doi: 10.1210.
    PubMed         Abstract available

  18. AZIZI F, Mehran L, Abdi H, Amouzegar A, et al
    Approach to the Patient Considering Long-term Antithyroid Drug Therapy for Graves' Disease.
    J Clin Endocrinol Metab. 2024 Jul 9:dgae456. doi: 10.1210.
    PubMed         Abstract available


    J Nephrol

  19. BALTU D, Serin O, Aksu T, Hizarcioglu Gulsen H, et al
    Membranoproliferative glomerulonephritis in a patient with lysinuric protein intolerance: lesson for the clinical nephrologist.
    J Nephrol. 2024 Jul 17. doi: 10.1007/s40620-024-02018.
    PubMed        


    J Neurol

  20. MOLENAAR PCG, Noteboom S, van Nederpelt DR, Krijnen EA, et al
    Digital outcome measures are associated with brain atrophy in patients with multiple sclerosis.
    J Neurol. 2024 Jul 15. doi: 10.1007/s00415-024-12516.
    PubMed         Abstract available

  21. RAVANO V, Andelova M, Piredda GF, Sommer S, et al
    Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis.
    J Neurol. 2024 Jul 13. doi: 10.1007/s00415-024-12568.
    PubMed         Abstract available


    Lancet Neurol

  22. NARAYANASWAMI P, Sanders DB
    Azathioprine and mycophenolate mofetil in myasthenia gravis - Authors' reply.
    Lancet Neurol. 2024;23:762-763.
    PubMed        

  23. VINCIGUERRA C, Milella G, Monastero R, Brighina F, et al
    Azathioprine and mycophenolate mofetil in myasthenia gravis.
    Lancet Neurol. 2024;23:762.
    PubMed        


    Neurology

  24. SASTRE-GARRIGA J, Vidal-Jordana A, Toosy AT, Enzinger C, et al
    Value of Optic Nerve MRI in Multiple Sclerosis Clinical Management: A MAGNIMS Position Paper and Future Perspectives.
    Neurology. 2024;103:e209677.
    PubMed         Abstract available

  25. WILLIAMS MJ, Amezcua L, Cohan SL, Cohen JA, et al
    Efficacy of Ofatumumab and Teriflunomide in Patients With Relapsing MS From Racial/Ethnic Minority Groups: ASCLEPIOS I/II Subgroup Analyses.
    Neurology. 2024;103:e209610.
    PubMed         Abstract available


    PLoS One

  26. PIKULIN S, Yehezkel I, Moskovitch R
    Enhanced blood glucose levels prediction with a smartwatch.
    PLoS One. 2024;19:e0307136.
    PubMed         Abstract available

  27. SUMIMOTO H, Noda S, Koide H, Douke Y, et al
    Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitors.
    PLoS One. 2024;19:e0306995.
    PubMed         Abstract available

  28. CAMPANIONI S, Veiga C, Prieto-Gonzalez JM, Gonzalez-Novoa JA, et al
    Explainable machine learning on baseline MRI predicts multiple sclerosis trajectory descriptors.
    PLoS One. 2024;19:e0306999.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.